These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Resolution of inflammation, statins, and plaque regression. Moreno PR; Kini A JACC Cardiovasc Imaging; 2012 Feb; 5(2):178-81. PubMed ID: 22340824 [No Abstract] [Full Text] [Related]
7. Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry. Philipp S; Böse D; Wijns W; Marso SP; Schwartz RS; König A; Lerman A; Garcia-Garcia HM; Serruys PW; Erbel R Eur Heart J; 2010 Jan; 31(2):196-202. PubMed ID: 19854730 [TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
9. Time course of atherosclerosis regression. Spence JD Atherosclerosis; 2014 Aug; 235(2):347-8. PubMed ID: 24911639 [No Abstract] [Full Text] [Related]
10. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. Gumprecht J; Gosho M; Budinski D; Hounslow N Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889 [TBL] [Abstract][Full Text] [Related]
11. High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor. Fukutomi T; Takeda Y; Suzuki S; Ito T; Joh T; Itoh M Int J Cardiol; 2010 Jun; 141(3):320-2. PubMed ID: 19138801 [TBL] [Abstract][Full Text] [Related]
12. TRPV1: a useful therapeutic target for patients with vulnerable coronary plaques. Li YB; Huang CX Med Hypotheses; 2011 Sep; 77(3):453-5. PubMed ID: 21733634 [TBL] [Abstract][Full Text] [Related]
13. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Girotra S; Murarka S; Migrino RQ Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562 [TBL] [Abstract][Full Text] [Related]
14. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress. Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484 [TBL] [Abstract][Full Text] [Related]
15. Pitavastatin (Livalo)--the seventh statin. Med Lett Drugs Ther; 2010 Jul; 52(1343):57-8. PubMed ID: 20651638 [No Abstract] [Full Text] [Related]
16. Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial. Eriksson M; Budinski D; Hounslow N Adv Ther; 2011 Sep; 28(9):811-23. PubMed ID: 21874538 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of pitavastatin versus simvastatin. Eriksson M; Budinski D; Hounslow N Adv Ther; 2011 Sep; 28(9):799-810. PubMed ID: 21874537 [TBL] [Abstract][Full Text] [Related]